In addition to the upregulation of AMPs in the nasopharynx during SARS-CoV-2 infection, we observed increased gene expression profiles of IFN-γ, TNF-ɑ, and IL-6 in COVID-19 patients, which was further confirmed at the protein level for IFN-γ and IL-6. The gene discussed is ADSL; the disease is COVID-19.